In an effort to combat three of the most dangerous respiratory infections that circulate annually, Moderna is marketing a vaccine that combines protection against COVID-19, the flu, and respiratory syncytial virus. Canada is experiencing an increase in pediatric RSV cases, ...
In a world where the pressure grows for those who aren’t willing to receive COVID vaccination, companies are testing their shots on children. Moderna, the company that developed one of the most well-known vaccines for COVID, announced that it expects ...
The American pharmaceutical company released data from a new study about the Covid-19 vaccine on children aged 6 to 11. The FDA, EMA, and other health regulators will receive the data in the near future. For the clinical study, 4,753 children under ...